Vidyalakshmi Devarajan

Suggest Changes
Learn More
Background Superiority of colistin-carbapenem combination therapy (CCCT) over colistin monotherapy (CMT) against carbapenem-resistant Gram-negative bacterial (CRGNB) infections is not conclusively(More)
  • 1